gross profit bridgeinconsistent2024-12-31
Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.
Revenue
$73.07K
Fiscal year ended 2025-12-31Operating income
-$14.19M
Fiscal year ended 2025-12-31Free cash flow
Unavailable
Fiscal year ended 2025-12-31Endovia Health Sciences, Inc. (EDVA) reported revenue of $73.07K and net income of -$25.23M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Endovia Health Sciences, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Beverages.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $73.07K | $801.27K | $18.85M | $18.09M | $11.32M | $2.30M | $20.39K | $1.31M | $895.35K | $1.01M |
| Cost of revenue | Unavailable | Unavailable | $13.28M | $12.17M | $7.40M | $1.94M | $245.50K | $605.27K | $440.42K | $484.91K |
| Gross profit | $16.90K | Unavailable | $5.57M | $5.92M | $3.92M | $363.59K | -$225.11K | $703.90K | $454.93K | $527.38K |
| Operating income | -$14.19M | -$9.90M | -$15.29M | -$21.39M | -$29.08M | -$17.66M | -$4.49M | $66.68K | -$157.21K | -$50.00K |
| Net income | -$25.23M | -$23.76M | -$21.00M | -$21.69M | -$29.05M | -$28.67M | -$5.14M | $68.21K | -$147.53K | -$48.85K |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 2.18M | shares 1.34M | shares 1.06M | shares 37.39M | shares 28.90M | shares 18.54M | shares 11.94M | shares 11.39M | Unavailable | Unavailable |
| Pretax income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Income tax expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Diluted EPS | $-11.97 | $-17.68 | Unavailable | Unavailable | $-1.02 | $-1.06 | $-0.04 | $0.01 | Unavailable | Unavailable |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $204.08K | $194.31K | $162.53K | $136.06K |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | $79.01K | $483.52K | $2.49M | $2.81M | $787.83K | $146.58K | $67.47K | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $281.44K | $13.79K | $379.98K | $4.43M | $4.18M | $380.00K | $42.64K | $938.04K | Unavailable | Unavailable |
| Total assets | $965.69K | $2.76M | $9.90M | $17.30M | $16.39M | $9.23M | $605.31K | $408.30K | $241.03K | $355.33K |
| Current assets | $631.99K | $1.90M | $3.98M | $10.66M | $8.34M | $2.24M | $370.66K | $349.67K | $194.39K | $293.14K |
| Total liabilities | $16.27M | $21.39M | $15.50M | $7.98M | $7.51M | $9.33M | $10.36M | $410.95K | $313.89K | $315.66K |
| Current liabilities | $16.26M | $19.37M | $14.75M | $4.97M | $6.48M | $5.42M | $10.28M | $405.46K | $299.88K | $290.36K |
| Total equity incl. NCI | -$15.30M | -$18.63M | -$5.61M | $9.32M | $8.87M | -$9.35M | -$9.76M | -$7.83M | -$72.86K | $39.67K |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $33.54K | $319.10K | $2.25M | $3.72M | $1.92M | $798.27K | $304.01K | $41.70K | Unavailable | Unavailable |
| Accounts receivable | $15.75K | $191.99K | $890.63K | $1.81M | $1.11M | $484.86K | $11.43K | $300.99K | $151.26K | $206.25K |
| Goodwill | Unavailable | Unavailable | $256.82K | $256.82K | $256.82K | $5.67M | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt | $3.42K | $1.97M | $457.66K | $2.54M | $0 | $1.24M | $2.06K | $5.50K | $14.01K | $25.30K |
| Accounts payable | $4.81M | $3.59M | $4.44M | $3.38M | $1.91M | $1.52M | $703.90K | $331.03K | $226.21K | $209.07K |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$4.82M | -$7.30M | -$10.19M | -$14.04M | -$14.70M | -$21.32M | -$2.66M | $62.39K | -$17.60K | $32.11K |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | Unavailable | -$3.24K | -$14.11K | -$102.70K | $0 | -$768.62K | -$12.55K | -$67.57K | -$42.23K | -$52.08K |
| Financing cash flow | $5.10M | $7.54M | $6.15M | $14.45M | $19.01M | $22.49M | $1.78M | -$5.76K | $16.09K | $74.28K |
| Net change in cash | $267.65K | -$153.38K | -$4.05M | $250.36K | $3.80M | $337.36K | -$895.40K | Unavailable | Unavailable | Unavailable |
| Stock-based compensation | $8.62M | $2.36M | $1.17M | $7.41M | $3.97M | $2.33M | $1.62M | $0 | Unavailable | Unavailable |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $9.28K | $401.60K | $545.98K | $936.02K | $111.57K | $113.30K | $9.33K | Unavailable | Unavailable | Unavailable |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | 23.1% | -15.0% | 29.5% | 32.7% | 34.6% | 15.8% | -1104.2% | 53.8% | 50.8% | 52.1% |
| Operating margin | -19415.6% | -1235.6% | -81.1% | -118.3% | -257.0% | -767.9% | -22009.4% | 5.1% | -17.6% | -4.9% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 11802.4% | 294.1% | 6.2% | 41.0% | 35.1% | 101.3% | 7946.7% | 0.0% | Unavailable | Unavailable |
| Current ratio | 0.04x | 0.10x | 0.27x | 2.15x | 1.29x | 0.41x | 0.04x | 0.86x | 0.65x | 1.01x |
| Revenue YoY growth | -90.9% | -95.7% | 4.2% | 59.8% | 392.0% | 11182.3% | -98.4% | 46.2% | -11.6% | Unavailable |
| Net margin | -34537.0% | -2964.9% | -111.4% | -119.9% | -256.7% | Unavailable | -25191.2% | 5.2% | -16.5% | -4.8% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | 0.64x |
| Effective tax rate | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open EDVA in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-19View SEC filing
10-Q · Filed 2026-05-20View SEC filing
10-K · Filed 2026-04-15View SEC filing
10-Q · Filed 2025-11-19View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-K · Filed 2025-07-11View SEC filing
Reconciliation checks needing review
3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2020-12-31
Difference 9248720 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2018-12-31
Difference 7828473 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.